📖
L-Tetrahydropalmatine, a Novel Dopamine Antagonist, Fails to Improve Psychiatric Symptoms as Adjunctive Treatment for Schizophrenia.
Ponomareva OY, Redman B, Sayer MA, Wehring HJ, Vyas G, Richardson CM, Gold JM, Gorelick DA, Cihakova D, Talor MV, Hoag SW, Buchanan RW, Wang J, Chen S, Liu F, Wang JB, Kelly DL

L-Tetrahydropalmatine, a Novel Dopamine Antagonist, Fails to Improve Psychiatric Symptoms as Adjunctive Treatment for Schizophrenia.

Medicine & Health Published 2020 Verification Pending

Overview & Synopsis

Open access biomedical research article published in Schizophr Bull Open.

Indexed from repository: PubMed Central (pmc.ncbi.nlm.nih.gov)
Loading document from verified source...
Keyboard Shortcuts: ← / → for pages • + / - for zoom • 0 to fit width Powered by Mozilla PDF.js v3.11

Document Information

Document Title L-Tetrahydropalmatine, a Novel Dopamine Antagonist, Fails to Improve Psychiatric Symptoms as Adjunctive Treatment for Schizophrenia.
Author / Organization Ponomareva OY, Redman B, Sayer MA, Wehring HJ, Vyas G, Richardson CM, Gold JM, Gorelick DA, Cihakova D, Talor MV, Hoag SW, Buchanan RW, Wang J, Chen S, Liu F, Wang JB, Kelly DL
Subject & Discipline Schizophr Bull Open
Categories Medicine & Health
Publication Year 2020
License / Rights Open Access / Creative Commons
Resource Verification Listed PDF (Verification Pending)
Original Host Website PubMed Central (pmc.ncbi.nlm.nih.gov)
File Format application/pdf (Portable Document Format)
Language EN
Catalog ID DOC-118779
Original Source Link Visit Source Page on pmc.ncbi.nlm.nih.gov »